Chinese biotech startup Lepu Biotech has raised an aggregate of 1.291 billion yuan ($186 million) in a Series B round co-led by Ping An Insurance (Group)’s investment vehicle Ping An Capital and Sunshine Insurance Group-backed private equity firm Riverhead Capital Investment Management.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
